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NADPH-cytochromeP450 reductase is a key compo-
nent of the P450 mono-oxygenase drug-metabo-
lizing system. There is evidence for a conformational
equilibrium involving large-scale domain motions in
this enzyme. We now show, using small-angle
X-ray scattering (SAXS) and small-angle neutron
scattering, that delivery of two electrons to cyto-
chromeP450 reductase leads to a shift in this equilib-
rium from a compact form, similar to the crystal
structure, toward an extended form, while coenzyme
binding favors the compact form. We present a
model for the extended form of the enzyme based
on nuclear magnetic resonance and SAXS data.
Using the effects of changes in solution conditions
and of site-directed mutagenesis, we demonstrate
that the conversion to the extended form leads to
an enhanced ability to transfer electrons to cyto-
chrome c. This structural evidence shows that
domain motion is linked closely to the individual
steps of the catalytic cycle of cytochrome P450
reductase, and we propose a mechanism for this.
INTRODUCTION
Proteins show internal motions over a wide range of timescales
(picoseconds to seconds) and amplitudes (0.01 to >50 A˚), and
it is clear that at least some of thesemotions contribute to biolog-
ical function—notably, in enzyme catalysis. The idea of an
energy landscape for a folded protein is well established
(Frauenfelder et al., 1991), and recent structural evidence has
shown that some of the conformational substates of unliganded
enzymes correspond to states along the reaction coordinate,
leading to the idea of the importance of ‘‘conformational selec-
tion’’ (e.g., Boehr et al., 2009; Hammes et al., 2011; Ma and Nus-
sinov, 2010). Many of the motions involved in these processes
are relatively local—notably, loopmovements—and for a few en-
zymes, the ‘‘choreography’’ of these motions in the catalytic cy-Strucle has been studied in detail (Boehr et al., 2010; Eisenmesser
et al., 2005; Henzler-Wildman et al., 2007). However, there are
instances where much larger scale movements of whole do-
mains are essential in enzyme turnover (e.g., Qi and Hayward,
2009; Reger et al., 2008; Wolthers et al., 2010) and, notably, in
electron transfer pathways. Electron transfer is generally carried
out by proteins associated in large dynamic complexes; in such
systems, domain motion can be required to provide access for
the protein partner(s) to the redox center(s), and the importance
of large-scale protein dynamics in biological electron transfer is
now recognized (e.g., Danyal et al., 2010; Lennon et al., 2000;
Toogood et al., 2007).
There is evidence for domain motion in the family of diflavin
reductases, which includes cytochrome P450 reductase (CPR)
(Iyanagi et al., 2012; Wang et al., 1997; Xia et al., 2011b), nitric
oxide synthase (Haque et al., 2012; Iyanagi et al., 2012; Stuehr
et al., 2009), and methionine synthase reductase (Wolthers
et al., 2007). These enzymes have three domains: an FMN-bind-
ing domain, related to flavodoxins; an FAD- and NADPH-binding
domain, related to ferredoxin/flavodoxin reductases; and a
‘‘linker’’ domain, the FMN domain being connected to the linker
and FAD domains through a highly flexible ‘‘hinge.’’ CPR is a key
component of the P450 mono-oxygenase system of the endo-
plasmic reticulum, which plays a central role in drug metabolism
(Riddick et al., 2013). Cytochromes P450 (P450s) catalyze the
insertion of one atom of molecular oxygen into their substrates
with the reduction of the other atom to water, a reaction requiring
two electrons which, in the case of the drug-metabolizing P450s,
are supplied by CPR (Iyanagi et al., 2012; Murataliev et al., 2004).
CPR accepts electrons from the obligatory two-electron donor
NADPH on to its FAD cofactor and transfers them via its FMN
cofactor to a wide range of different P450s. The two electrons
are donated one at a time at two distinct steps in the P450 reac-
tion cycle (Makris et al., 2005; Murataliev et al., 2004).
The conformation of truncated soluble CPR seen in the crystal
(Wang et al., 1997; Xia et al., 2011b) is well suited for electron
transfer from FAD to FMN, as the two isoalloxazine rings are
<4 A˚ apart. However, in this conformation, it is difficult to see
how the large P450 (or cytochrome c, widely used as a surrogate
redox partner for studies in solution) could approach close
enough to the FMN for electron transfer to occur (Aigrain et al.,
2012). The implication is that the domains of CPR must movecture 21, 1581–1589, September 3, 2013 ª2013 The Authors 1581
Figure 1. Intraparticle Distance Distribution Functions Derived from
SAXS of CPR in the Oxidized and Reduced States
Blue, oxidized enzyme; red, enzyme reduced to the two-electron level by
careful anaerobic titration with dithionite, monitored by optical absorption
spectroscopy; yellow, enzyme reduced to the two-electron level by addition of
stoichiometric NADPH.
See also Figures S1 and S2.
Table 1. Hydrodynamic Parameters for Oxidized and Reduced
CPR Obtained from Solution Scattering Experiments
Sample Rg (SAXS) (A˚) Dmax (SAXS) (A˚) Rg (SANS) (A˚)
Oxidized 26.4 73 24.8
Dithionite 2e-reduced 28.8 80 29.0
NADPH 2e-reduced 27.6 76 27.8
NADH 2e-reduced 29.3 83 –
Dithionite 2e-
reduced + NADP+
27.7 78 –
Errors were in the range ±0.1–0.4 A˚ for SAXS Rg values, ±0.4–0.6 A˚ for
SANS Rg values, and ±1–2 A˚ for Dmax values.
See also Figures S1 and S3.
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Redox-Linked Domain Movements in P450 Reductaserelative to one another to allow access of the redox partners to
the FMN, and there is circumstantial evidence for this from our
own and other laboratories (Aigrain et al., 2012; Ellis et al.,
2009; Grunau et al., 2007; Gutierrez et al., 2002, 2003; Hamdane
et al., 2009; Hay et al., 2010; Iyanagi et al., 2012; Jenner et al.,
2011; Pudney et al., 2011; Xia et al., 2011a).We have shown (Ellis
et al., 2009; Jenner et al., 2011) that, in solution, the wild-type
human enzyme can adopt an extended conformation resulting
from a substantial domain movement. We now report detailed
studies of the conformational equilibrium of CPR in solution
using small-angle X-ray scattering (SAXS) and small-angle
neutron scattering (SANS) methods and present a model of the
extended state based on nuclear magnetic resonance (NMR)
and SAXSdata. The effects of redox state and coenzyme binding
on the position of the equilibrium allow us to relate the domain
movement to individual steps in the catalytic cycle of the
enzyme.
RESULTS
Reduction Converts CPR from a Compact to an
Extended Conformation
We have shown, using SAXS and ion-mobility mass spectrom-
etry, that CPR having both flavins in the oxidized state (CPRox)
exists in equilibrium between compact and extended conforma-
tions (Ellis et al., 2009; Jenner et al., 2011). These SAXS exper-
iments, carried out at the Science and Technology Facilities
Council (STFC) Synchrotron Radiation Source (Daresbury, UK)
using a wavelength of 1.53 A˚ and long exposure times (25–
60 min), suggested that CPRox consisted of a roughly 50:50
mixture of compact and extended conformations (Ellis et al.,
2009), whereas the mass spectrometry experiments suggested
a much smaller (15%) proportion of the extended conforma-
tion (Jenner et al., 2011). Figure 1 shows the intraparticle1582 Structure 21, 1581–1589, September 3, 2013 ª2013 The Authodistance distribution function, P(r), for CPRox and for two-elec-
tron-reduced CPR (CPR2e, produced by addition of either di-
thionite or NADPH), calculated from SAXS experiments carried
out using a wavelength of 0.931 A˚ and a much shorter exposure
time (0.5 s); very similar results were obtained using a continu-
ously flowing sample to further minimize exposure. (The scat-
tering curves are shown in Figure S1 available online.) The
data for CPRox are consistent with a compact conformation,
whose radius of gyration (Rg) of 26.4 A˚ (Table 1) is closely similar
to the value of 26.6 A˚ for the Rg of the hydrated molecule calcu-
lated from the crystal structure (Wang et al., 1997). The results of
these SAXS experiments are clearly more similar to those of our
mass spectrometry experiments (Jenner et al., 2011) on CPRox
than to our earlier SAXS results (Ellis et al., 2009). There is evi-
dence that flavins in protein crystals can be reduced by photo-
electrons produced by exposure to high X-ray doses (Berkholz
et al., 2008; Johansson et al., 2010; Kort et al., 2004), and this
has been demonstrated by Raman spectroscopy (Røhr et al.,
2010). We have now shown by optical spectroscopy that the fla-
vins of CPR are also reduced during X-ray exposure in solution
(Figure S2). This suggests that the SAXS results reported earlier
(Ellis et al., 2009) for ‘‘oxidized’’ CPR may, in fact, have corre-
sponded to a mixture of oxidized enzyme and enzyme reduced
to the disemiquinone level, because of partial reduction by
X-ray-induced photoelectrons, leading to a substantial overesti-
mate of the proportion of the extended conformation in the
oxidized state.
To avoid any possibility of partial reduction during the experi-
ment, we carried out SANS experiments on CPR; the Rg values
for CPRox and CPR2e are given in Table 1, and the Guinier plots
are shown in Figure S3. The SANS observations confirm that, in
the oxidized state, CPR adopts a compact conformation. the
direct comparison of the Rg values obtained by SAXS and
SANS is complicated by the different effects of hydration in the
two experiments (Perkins, 2001; Svergun et al., 1998).
Comparison of the P(r) curves in Figure 1 clearly shows a
longer ‘‘tail’’ to the distribution at large r values for CPR2e pro-
duced by dithionite reduction, leading to a value for the
maximum dimension, Dmax, of 80 A˚, as compared to 73 A˚ for
the oxidized enzyme (Table 1). The SANS data confirm that
CPR2e adopts an extended conformation, with an Rg as much
as 4 A˚ greater than in the oxidized state (Table 1).
Both SANS experiments and short-exposure
SAXS experiments demonstrate that reduction of CPR to thers
Figure 2. Chemical Shift Differences for Residues in the FMN
Domain between the Intact Enzyme and Isolated Domain, Mapped
onto the Crystal Structure
The linker and FAD domains are shown in green, and the flavin cofactors in
space-filling representation. In the FMN domain, residues showing combined
(1H and 15N) backbone chemical shift differences between the isolated domain
(Barsukov et al., 1997; Ellis et al., 2009) and the intact enzyme (see Experi-
mental Procedures) of >0.3 ppm, >0.15 ppm, and <0.15 ppm are indicated in
red, magenta, and gray, respectively. Residues in the FMN domain whose
cross-peaks are too broad to detect are indicated in cyan.
See also Figure S4.
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proportion of an extended conformation, showing clearly that the
domain movement in this enzyme is linked to the catalytic cycle.
Effect of Coenzyme Binding on the Position of the
Conformational Equilibrium
It is notable that reduction of CPR to the two-electron level by
stoichiometric NADPH rather than by dithionite yields a more
compact conformation of the enzyme (Figure 1; Table 1). Under
the conditions of these experiments, the product NADP+ is
expected to remain bound to the enzyme (the dissociation con-
stant, KD, of NADP
+ for CPRox is 53 nM; Grunau et al., 2006),
giving CPR2e , NADP+. Indeed, addition of NADP+ to CPR2e
(obtained by dithionite reduction) leads to a more compact state
of the enzyme (Table 1). By contrast, reduction by stoichiometric
NADH yields an Rg value similar to that obtained by dithionite
reduction (Table 1); NAD+ binds only weakly, so that reduction
by NADH or by dithionite would both yield coenzyme-free
CPR2e.
These experiments indicate that, while two-electron-reduction
of CPR in the absence of coenzyme shifts the conformationalStruequilibrium toward an extended conformation, coenzyme bind-
ing shifts it back toward a compact conformation.
AModel for the Structure of the Extended Conformation
of CPR
We have obtained an approximate model of the extended
conformation of oxidized CPR using the program HADDOCK
(Dominguez et al., 2003), allowing the FMN domain to move rela-
tive to the rest of the protein, subject to the constraints of (1) the
length of the flexible ‘‘hinge’’ between the domains, (2) the
molecular envelope obtained from SAXS experiments at high
ionic strength (discussed later), and (3) a number of identified
residues whose environment differs between intact CPR and
the isolated FMN domain, as indicated by differences in NMR
chemical shifts (Figure S4).
The structure of the isolated FMN domain (Zhao et al., 1999) is
closely similar to that of the domain in CPR (root-mean-square
deviation = 0.25 A˚), so we hypothesized that these shift differ-
ences, shown on the crystal structure in Figure 2, report on
domainmovements not on structural changeswithin the domain.
Residues in loops close to the FMN, notably 85–92 and 139–144,
whose environment in CPR will clearly be different from that in
the isolated domain, show significant shift differences. However,
the largest chemical shift differences, almost 1 ppm, together
with extensive line broadening, are seen for residues in the first
half of helix 212–231 (helix F), which are largely solvent exposed
in the crystal structures of both CPR (Xia et al., 2011b) and the
FMN domain (Zhao et al., 1999). More modest shift differences
are also seen for residues in helix A, at the far end of the domain
from the FMN. These observations suggest the existence in so-
lution of some population of a conformation differing from that
seen in the crystal structure.
The model of the extended conformation is compared to the
crystal structure in Figure 3. Regions of the FMN domain
involved in interdomain interactions are shown in dark blue. In
the crystal structure, these primarily involve loops around the
FMN, but, in addition, two residues near the N termini of helices
B and F (E96, E216) interact with residues (R285 and T386) at the
N terminus of helix I in the linker domain (Figure 3, shown in
magenta). In the model of the extended conformation, these
three helices interact much more extensively, involving almost
the whole length of helix I. The residues of these helices, partic-
ularly those involved in these interdomain interactions, are highly
conserved (Figure S5). Thus, the loss of the interdomain interac-
tions of the loops around the FMN is compensated by the much
more extensive interactions between helices B and F in the FMN
domain and helix I in the linker domain. Comparing our model of
the extended conformation to the crystal structure, it is apparent
that a major difference between the two arises from a rotation of
the FMN domain over the surface of the linker domain, leading to
the FMN becoming solvent accessible (Figure 3).
The Extended Conformation of CPR Is Functionally
Important
Increasing ionic strength affects the rates of CPR-catalyzed
reduction of P450s or of cytochrome c (e.g., Davydov et al.,
2000; Jang et al., 2010; Sem and Kasper, 1995), leading to an in-
crease both in catalytic rate constant, kcat, and in Michaelis-
Menten constant, KM, for cytochrome c (Figure S6). There iscture 21, 1581–1589, September 3, 2013 ª2013 The Authors 1583
Figure 4. Effects of Ionic Strength on the Shape and Catalytic Activ-
ity of CPR
(A) Intraparticle distance distribution functions of CPR at different ionic
strengths (100 mM BES, pH 7.0, plus varying concentrations of NaCl).
(B) Molecular shapes derived from the solution scattering data using the
program GASBOR.
(C) Correlation between the Dmax values and the kcat values for cytochrome c
reduction at different ionic strengths (R2 = 0.98).
See also Figure S6 and Table S1.
Figure 3. The Compact and Extended Conformations of CPR
(A) Compact conformation, represented by the crystal structure.
(B) Model of the extended conformation of CPR, derived as described in the
text. The flavin cofactors are shown in space-filling representation (FMN, slate
blue; FAD, yellow). The linker and FAD domains are shown in green, except for
helix I in the linker domain, discussed in the text, which is shown in magenta.
The FMN domain is in gray, except for residues involved in interdomain con-
tacts in the two conformations, which are shown in dark blue. Mutated
residues are shown, with their side chains, in red; residues D352 and E354,
discussed in the text, are shown in cyan.
See also Figure S5.
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Redox-Linked Domain Movements in P450 Reductaseevidence that ion-pair interactions are involved in CPR-cyto-
chrome interactions (Bridges et al., 1998; Shen and Kasper,
1995; Zhao et al., 1999), so that an increase in KMwith increasing
ionic strength would be expected, although the reason for the in-
crease in kcat is less apparent. The crystal structures of CPR
(Wang et al., 1997; Xia et al., 2011b) show that the domain-
domain interface around the FAD and FMN cofactors includes
a number of ion-pair interactions, raising the possibility that
increasing ionic strength would affect the position of the confor-
mational equilibrium. SAXS experiments show that CPR be-
comes more elongated at high ionic strength. Increasing the
ionic strength up to 0.24 M has no significant effect, but further
increases lead to a marked elongation of the molecular envelope
until, by I = 0.54 M, Rg has increased from 26.4 A˚ to 32.5 A˚ and
Dmax has increased from 74 A˚ to 108 A˚ (Figure 4A; Table S1). The
effect of high salt is completely reversible on decreasing the salt
concentration by dialysis. These results are consistent with the
idea that oxidized CPR exists in equilibrium between compact
and extended conformations, the position of which is sensitive
to the ionic strength of the solution. As the ionic strength is var-
ied, we observe a striking correlation between kcat andDmax (Fig-1584 Structure 21, 1581–1589, September 3, 2013 ª2013 The Authoure 4C); this can readily be understood if the extended form of
the enzyme, favored at high ionic strength, is required for inter-
molecular electron transfer.
To further test the importance of the extended conformation
for the activity of CPR, we have constructed mutants involving
residues at interdomain interfaces or in the flexible hinge. The
positions of the residues involved are shown in Figure 3, and
the shapes of these mutants and their kinetic constants for cyto-
chrome c reduction are given in Table 2. The mutation V233P/
E234P, involving two residues at the very beginning of the flex-
ible ‘‘hinge,’’ remote from the linker and FAD domains, leads to
a substantial increase in the Rg and Dmax values, indicating a
larger population of the extended conformation, a 3-fold
decrease in the KM for cytochrome c and a slight increase in
kcat. The FMN domain of CPR has clusters of negatively charged
residues around the FMN binding site and a striking patch of
positively charged residues at the opposite end of the domain.
In the crystal structure, two of these latter residues, K75 and
R78, make salt bridges to two residues, E354 and D352, respec-
tively, on the surface of the linker domain, while in our model ofrs
Table 2. Kinetic and Hydrodynamic Parameters of CPR Mutants
Protein
KM
cytochrome c
(mM) kcat (s
1) Rg (A˚) Dmax (A˚)
Wild-type 2.4 ± 0.6 21.2 ± 0.4 26.4 ± 0.1 73 ± 1
K75E/R78E/R108Q 0.46 ± 0.05 44.0 ± 0.5 29.3 ± 0.3 93 ± 2
V233P/E234P 0.7 ± 0.6 26.9 ± 0.3 31.2 ± 0.2 108 ± 2
Structure
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and the relevant residues are >15 A˚ distant from one another
(Figure 3). We have shown earlier that neutralization of the latter
residues in the mutant D352N/E354Q leads to a substantial in-
crease in the population of the extended conformation, from
15% to 65% (Jenner et al., 2011). Charge reversal mutations in
the interacting positively charged residues in the FMN domain,
in the mutant K75E/R78E/R108Q, lead to a substantial increase
in Rg, consistent with an increased population of the extended
conformation (Table 2). It is striking that this mutant also shows
a 5-fold decrease in the KM for cytochrome c and a doubling of
kcat for cytochrome c reduction, providing further support for
the importance of the conformational equilibrium for the activity
of the enzyme.
Both the effects of increasing ionic strength and those of mu-
tation show a correlation between an increase in the extended
conformation and increased activity in cytochrome c reduction,
demonstrating that this conformation plays a key role in the cat-
alytic cycle.
DISCUSSION
The data presented here show clearly that, in solution, CPR ex-
ists in equilibrium between a compact conformation and a more
extended conformation and that this equilibrium is linked to
redox state and catalytic turnover.
The Conformational Equilibrium in CPRox
For the oxidized enzyme, the Rg values and the molecular enve-
lope derived from our solution scattering experiments are essen-
tially consistent with the compact conformation seen in the crys-
tal. In a recent NMR study of the oxidized enzyme, Vincent et al.
(2012) showed that a partial set of 1H-15N residual dipolar cou-
plings was consistent with the compact conformation as seen
in the crystal, with a maximum of 5%–7.5% of an extended
conformation. Our earlier ion-mobility mass spectrometry
studies (Jenner et al., 2011) indicated that, in CPRox, the
extended conformation represents approximately 15% of the
population, in broad agreement with these results. The differ-
ence from our conclusions from earlier SAXS experiments (Ellis
et al., 2009) arises from partial reduction of the flavins by
X-ray-induced photoelectrons in those experiments. Compari-
son with our SANS data shows that this can be avoided by the
use of short wavelengths and, particularly, short exposure times
in SAXS.
There have been two reports of crystal structures of ‘‘open’’
conformations of CPR: a rat CPR mutant, DTGEE, in which
four residues were deleted from the hinge region (Hamdane
et al., 2009), and a chimeric enzyme consisting of the FMN
domain from yeast CPR with the hinge and the linker and FADStrudomains from human CPR (Aigrain et al., 2009). In both these
structures, residues that show chemical shift differences be-
tween the isolated FMN domain and intact CPR remain solvent
exposed, and the calculated Rg value for the chimeric enzyme
is much greater than any value measured in the present work.
Thus, our model of the extended conformation derived from
data on wild-type CPR is not identical to either crystal structure.
It is, however, consistent with the behavior of the mutants K75E/
R78E/R108Q and D352N/E354Q, in which the interdomain salt
bridges K75-E354 and R78-D352 seen in the compact confor-
mation are abolished, since in our model of the extended confor-
mation these pairs of residues are distant from one another
(Figure 3).
Increasing the ionic strength leads to a marked increase in the
maximal dimension of the oxidized enzyme, consistent with a
shift in the position of the equilibrium between compact and
extended conformations as the salt concentration is increased,
and this is also shown by mass spectrometry (Jenner et al.,
2011). All our data, from SAXS, SANS, mutagenesis, and, partic-
ularly, mass spectrometry, are consistent with a two-state equi-
librium between the compact (crystal) structure and an extended
conformation. (Although ELDOR experiments on the disemiqui-
none form of CPR have been interpreted in terms of a multistate
conformational equilibrium; Hay et al., 2010.) Recent neutron
reflectometry studies (Wadsa¨ter et al., 2012) have suggested
the coexistence of compact and extended conformations ofSor-
ghum CPR incorporated in nanodiscs, suggesting that this equi-
librium is also relevant in a membrane environment.
Domain Movement in the Catalytic Cycle:
Synchronization with Electron Transfer
It is important to note that the SAXS and SANS experiments on
different states of CPR allow us to relate the position of the
conformational equilibrium to the catalytic cycle of the enzyme,
as indicated in Figure 5. Our structural evidence shows clearly
that CPR2e exists to a significant extent in an extended confor-
mation, which would allow P450s and cytochrome c to access
the FMN in this state of the enzyme. Scrutton and colleagues
(Pudney et al., 2011) have also suggested, from fluorescence
resonance energy transfer experiments, that reduction of the
enzyme leads to formation of an ‘‘open’’ form of the enzyme.
These experiments were carried out in phosphate buffer, which
binds to the coenzyme site (Grunau et al., 2006; Murataliev
et al., 2004), and the existence of multiple sites of labeling and
difficulties in deconvoluting the different contributions to the
emission responsemeans that they can be interpreted only qual-
itatively. However, they do provide additional evidence that for-
mation of the two-electron-reduced enzyme is accompanied by
domain movement. Binding of coenzyme to CPR2e shifts the
equilibrium back toward the compact form, but judging from
the Dmax values (Table 1), there is still a larger proportion of the
extended form than in the oxidized enzyme. The correlation in
the oxidized enzyme between Dmax (or the proportion of the
extended conformation) and the kinetic parameters for cyto-
chrome c reduction, seen both for changes in ionic strength
and for the effects of mutations, is consistent with a requirement
for the extended conformation for electron transfer to cyto-
chrome c. Accurate estimates of the equilibrium constant be-
tween the compact and extended conformations are not yetcture 21, 1581–1589, September 3, 2013 ª2013 The Authors 1585
Figure 5. Domain Movement in the Catalytic Cycle of CPR
Binding of NADPH to oxidized CPR followed by hydride ion transfer leads to
the CPR2e , NADP+ species, which is predominantly in a compact confor-
mation (Table 1; similar conclusions have been drawn from ELDOR experi-
ments; Hay et al., 2010). This is consistent with the obvious requirement for a
compact conformation, with the FAD and FMN in close proximity, for interflavin
electron transfer; and, indeed, the rate of interflavin electron transfer increases
on binding NADP+ (Gutierrez et al., 2002, 2003). Dissociation of NADP+ leads
to CPR2e, in which the extended conformation is substantially populated
(Table 1), facilitating electron transfer to P450 (or cytochrome c). The confor-
mations of CPRox and CPR2e , NADP+, while both predominantly compact,
are likely to be somewhat different. The coenzyme ‘‘fragment’’ 2050-ADP, which
binds remotely from any interdomain interface, increases the rate of interflavin
electron transfer in dithionite-reduced CPR (Gutierrez et al., 2003) and affects
the position of the conformational equilibrium (Ellis et al., 2009; Grunau et al.,
2006, 2007), suggesting that a tertiary structural change within the FAD
domain may occur on binding the 2050-ADPmoiety of the coenzyme and affect
the domain interface. After the transfer of the first electron, the enzyme is likely
to return to the compact state transiently to allow transfer of the second
electron from FAD to FMN; however, as yet, there is no experimental evidence
for the position of the equilibrium in CPR1e. The catalytic cycle shown is
based on the assumptions that CPR undergoes a 0-2-1-0 electron transfer
cycle and that the four-electron-reduced enzyme is not catalytically relevant
(Murataliev et al., 2004).
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Redox-Linked Domain Movements in P450 Reductaseavailable, but comparison of the Dmax value for CPR
2e with
those observed at high ionic strength suggests the existence
of a finely balanced equilibrium between the compact state,1586 Structure 21, 1581–1589, September 3, 2013 ª2013 The Authorequired for intramolecular electron transfer from FAD to FMN,
and the extended state, required for intermolecular electron
transfer from the FMN to cytochrome c or P450.A Proposed Mechanism for Domain Movement
In considering possiblemechanisms for the redox-linked domain
movement in CPR, a natural starting point is the effects of reduc-
tion on the flavins (Senda et al., 2009), which are at the domain
interface in the compact conformation. Flavin reduction will be
accompanied by protonation at N5 of the FMN and, therefore,
by altered hydrogen-bonding interactions at this atom. N5 is
positioned so that it might form a hydrogen bond to the peptide
NH of G141 when the flavin is oxidized and to its carbonyl when
the flavin is protonated in the semiquinone and hydroquinone
states. A reorientation of this peptide bond would thus be
required on formation of the neutral semiquinone and proton-
ation at N5; there is good evidence for this in flavodoxins (e.g.,
Hoover et al., 1999; Ludwig et al., 1997). In fact, close inspection
of the electron density map of the X-ray structure of human CPR
(Xia et al., 2011b) supports exactly such a role for G141 in CPR
(Figure 6). Density can clearly be seen that shows this peptide
bond in two positions, providing evidence for this peptide
bond reorientation and raising the possibility of partial reduction
in the published crystal structures. The next residue to G141 is
E142, which forms part of the interface between the FMN and
FAD domains. Thus, changes in the protonation state of N5 on
reduction could be transmitted to the interface, as the trigger
for domain motion.
In conclusion, the structural evidence reported here provides
clear support for the idea that, in CPR, the domain movement
necessary for enzyme turnover is not achieved simply by a
random diffusive motion of the FMN domain. Rather, domain
motion is linked closely to the individual steps of the catalytic cy-
cle of the enzyme, allowing a precise control of electron transfer
in this complex system.EXPERIMENTAL PROCEDURES
Materials
NADPH, 20,50-ADP, NADP+, NADH, dithionite, and horse heart cytochrome c
were purchased from Sigma-Aldrich. All other chemicals were of analytical
grade.Figure 6. The Structure and Experimental
Electron Density of Human CPR in the Vicin-
ity of the FMN Cofactor
The structure of human CPR (3QE2) is shown in
magenta, and the experimental electron density is
shown in blue. The Fo-Fc map is shown in green,
contoured at 3s, and clearly shows a second
conformation of the G141 peptide bond, which is
as seen in the rat enzyme (1AMO, superimposed in
yellow).
rs
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The gene for human fibroblast CPR lacking the N-terminal membrane-
anchoring region (a kind gift from Professor C.R. Wolf, University of Dundee)
was expressed in Escherichia coli BL21 Star and purified as described else-
where (Ellis et al., 2009). 2H,13C,15N-labeled CPR was produced from cells
grown in E. coli-OD2 CDN media (Silantes). Protein concentration was calcu-
lated using a molar extinction coefficient of ε450 nm = 22,000 M
1 cm1. Site-
directed mutagenesis was carried out using the Stratagene Quikchange II kit
using a standard protocol; custom oligonucleotides were purchased from
Eurofins MWG-Operon.
Enzyme Assay
Cytochrome c reduction assays were carried out by following absorbance
changes at 550 nm, in 100 mM BES [N,N-bis(2-hydroxyethyl)-2-amino-ethane
sulfonic acid], pH 7.0, at 25C, with 50 mM NADPH and variable cytochrome c
concentrations. Ionic strength was adjusted by addition of NaCl.
Solution Scattering Data Collection and Analysis
SAXS measurements were carried out using the SWING beamline at the SOL-
EIL synchrotron, Saint-Aubin, France. The beam wavelength was set to l =
1.033 A˚. The 17 3 17 cm2 low-noise Aviex CCD detector was positioned at
a distance of 2,107 mm from the sample, with the direct beam off-centered.
The resulting exploitable q range was 0.005–0.5 A˚1, where q = 4p sin q/l,
and 2q is the scattering angle. CPR samples at 0.5–10 mg ml1 in 100 mM
BES, pH 7.0, were analyzed by direct injection or high-performance liquid
chromatography (HPLC) mode. In the first case, they were transferred into
the SAXS flowthrough capillary cell, and a series of 50 frames was recorded.
In the second case, they were loaded into a size exclusion column (Agilent
Bio SEC-3, 300 A˚, 4.6 3 300 mm, 3 mm) using an Agilent HPLC system and
eluted into the SAXS flow-through capillary cell at a flow rate of 0.2 ml
min1. SAXS measurements were collected throughout the whole protein
elution time, with a frame duration of 1,000 ms and a dead time between
frames of 500 ms. Data processing, analysis, andmodeling steps were carried
out with PRIMUS (Konarev et al., 2003) and other programs of the ATSAS suite
(Konarev et al., 2006). Rgwas derived from the Guinier approximation (Guinier,
1939) and, together with the Dmax, P(r), and the forward scattering intensity,
was calculated using the indirect Fourier transform method with the program
GNOM (Svergun, 1992). Model-independent molecular shapes were calcu-
lated using GASBOR (Petoukhov and Svergun, 2003). Twenty independent
GASBOR runs were averaged using DAMAVER (Volkov and Svergun, 2003)
to obtain a typical molecular shape. Scattering profile simulations from crystal
coordinates were carried out using CRYSOL (Svergun et al., 1995).
SANS data were obtained on the LOQ small-angle diffractometer at the ISIS
Pulsed Neutron Source (STFC Rutherford Appleton Laboratory, Didcot, UK;
http://www.isis.stfc.ac.uk/) (Heenan et al., 1997). This is a fixed-geometry
‘‘white beam’’ time-of-flight instrument that utilizes neutrons with wavelengths
between 0.2 and 1 nm. Data are simultaneously recorded on two 2-dimen-
sional position-sensitive neutron detectors to provide a simultaneous q range
of 0.0816 nm1. Each sample was placed in a 2 mm path length quartz
cuvette and was measured for a total of 1 hr in order to gather data of high sta-
tistical precision. Each raw scattering data set was then corrected for the
detector efficiencies, sample transmission, and background scattering and
converted to scattering cross-section data (dS/dU versus q) using instru-
ment-specific software (Heenan et al., 1989; King and Heenan, 1995). These
data were placed on an absolute scale (cm1) using the scattering from a stan-
dard sample (a solid blend of hydrogenous and perdeuterated polystyrene) us-
ing established procedures (Wignall and Bates, 1987).
NMR Spectroscopy
Samples of 0.5 mM 2H,13C,15N-labeled CPRwere prepared in 30 mMBES, pH
6.5, containing 10% D2O. All NMR experiments were performed at 25
C on
Bruker AVANCE DRX 600 and AVANCE DRX 800 spectrometers equipped
with cryoprobes. Proton chemical shifts were referenced to external 4,4-
dimethyl-4-silapentane-1-sulfonic acid; the 15N and 13C chemical shifts were
referenced indirectly using recommended gyromagnetic ratios (Wishart
et al., 1995). Spectra were processed with Topspin (Bruker) and analyzed us-
ing Collaborative Computing Project for the NMR Community (CCPN) Analysis
(Vranken et al., 2005). Three-dimensional HNCO, HNCA, HNCOCA, HN(CA)StruCO, HNCACB, and HN(CO)CACB experiments were used to assign reso-
nances of CPR, focusing particularly on those of the FMN domain, using stan-
dard procedures (Lian and Barsukov, 2011). These partial assignments have
been deposited in the Biological Magnetic Resonance Bank under accession
number 19301. They are consistent with those of Vincent et al. (2012), as far as
can be judged from the spectrum in their SupplementaryMaterial; their assign-
ments are not yet available. It should be noted that their spectra were obtained
under different conditions of buffer, pH, and temperature from those used in
the present work. All cross-peaks were picked in the CPR spectrum, and
the chemical shift difference from the corresponding cross-peak in the spec-
trum of the FMN domain, Dd(HN,N), was calculated using the equation
DdðHN;NÞ=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Dd2H + 0:154Dd
2
N
q
;
where Dd = dCPR – dFMN. The chemical shifts were compared automatically us-
ing a computer script without any attempt to adjust the cross-peak mapping
between the two spectra. Resonances of a number of residues in the FMN
domain of intact CPR (indicated as asterisks in the histogram of Figure 4) could
not be identified in any of the triple-resonance spectra, most probably due to
exchange broadening.
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